Urea Breath Test Market

Urea Breath Test Market Size (2023 to 2028)

The global urea breath test market is estimated to be valued at USD 185.6 million by 2028 from USD 136.5 million in 2023, growing at a CAGR of 6.34% from 2023 to 2028.

Impact of COVID-19 on the global urea breath test market:

The urea breath test market has been significantly impacted by the global pandemic crisis. During the peak of the COVID-19 pandemic, many healthcare facilities shifted their focus on COVID-19 cases, which led to the disruption of regular healthcare services, including diagnostic tests like urea breath tests. Non-urgent medical procedures were postponed prioritizing COVID-19 patients to reduce the risk of virus transmission. Healthcare facilities globally focused on COVID-19 testing and treatment during the COVID-19 pandemic and resources were directed towards managing the pandemic, which might have impacted the availability and capacity for other diagnostic test such as the urea breath test. The COVID-19 pandemic crisis highlighted the importance of diagnostic testing, which led to increased research and development efforts in the field of diagnostic technologies. This drives the innovation in testing method, which make urea breath test more efficient, accessible, and adaptable.

MARKET DRIVERS:

The rising prevalence of gastric cancer and esophageal cancer primarily propel the growth of the urea breath test market. Globally, there were 1.8 million new cases of gastric cancer were recorded in 2022. H.pylori is a type of bacteria that can colonize the stomach lining and is a major cause of various gastrointestinal diseases, including gastritis, peptic ulcers and stomach cancer; detection and treatment of H.pylori infection is crucial for the prevention of these diseases and their associated complication. The urea breath test is a non-invasive and accurate method for detecting the presence of H.pylori in the stomach. It confirms the presence of the infection.

The growing product releases and approval are the second major factor fuelling the market growth. New technologies and methods are continually being developed to enhance the precision, sensitivity, and practicality of tests in the field of medical diagnostics. The effectiveness and reliability of new urea breath test items may be improved by technical innovations, making patients and healthcare professionals more likely to use them. The testing and receiving of results may be faster with new product releases due to reduced processes. Faster turnaround times are advantageous since they can hasten the diagnosis and treatment decision process for both patients and healthcare professionals, which is propelling the global market growth.

An increasing number of initiatives from the governments of several countries in favor of urea breath tests contributes to the growth of the global market. Governments frequently start public awareness programs to inform people about the value of early diagnosis and prevention of a variety of diseases, including those affecting the digestive system. These efforts have been emphasizing the value of urea breath testing for detecting and treating H. pylori infections, which is fuelling the demand for such tests. Governments have been allotting funds to support the development of medical facilities, medical research and programs that try to prevent and treat conditions, including stomach cancer and H. pylori infections. The funds can help with diagnostic test development and research, especially urea breath tests, and it can motivate medical professionals to include these tests in their routine care.

MARKET RESTRAINTS:

The presence of alternative tests for helicobacter pylori diagnosis is the major obstacle hindering market growth. Endoscopy, which involves inserting a small tube with a camera into the stomach to view the mucosa and obtain biopsies for the detection of H. pylori, is one of the main alternatives to the urea breath test. Endoscopy is an invasive treatment that necessitates sedation, has hazards, and is more expensive, even if it offers direct visualization and biopsy samples. Despite being invasive, it is still a widely used diagnostic technique, particularly when paired with biopsy, for determining cancer risk. Due to convenience, invasiveness, and potential discomfort, some patients may favor diagnostic techniques. These preferences may affect the selection of diagnostic tests, which may affect market demand. Regulatory compliance, safety concerns, and the shortage of qualified drivers further impede the global market growth.

REPORT COVERAGE:

This research report on the urea breath test market has segmented and sub-segmented the market based on test, product, instrument, end-user, and region.

Urea Breath Test Market – By Test Type:

• Point-of-Care Tests
• Laboratory-Based Test

Based on test type, the laboratory-based test segment is predicted to hold a promising share of the global market during the forecast period. Precision measurements of isotopic carbon dioxide levels in breath samples can be made through laboratory-based urea breath tests using specialized equipment in controlled settings. This high degree of precision contributes to the test results' dependability, which is essential for making accurate diagnoses and treatment choices. The laboratory-based urea breath test requires the use of sophisticated tools, frequently mass spectrometers, or infrared spectrometers, to analyze breath samples. These devices can produce extremely sensitive and precise findings by detecting even trace amounts of carbon dioxide isotopes.

The point-of-care test segment is expected to witness a prominent CAGR in the global market during the forecast period. Point-of-care breath tests with urea provide quick results, frequently in a few minutes. This short return time is especially helpful for situations where making an instant diagnosis and treatment decision is essential, enabling effective patient management. Without the need to transmit samples to centralized labs, point-of-care diagnostics can be carried out in clinical settings. Due to this simplicity, there are no more potential delays in sample transportation or laboratory processing.

Urea Breath Test Market – By Product Type:

• Breathe Analyzer
• UBT-Kits

Based on the product type, the breath analyzer segment is anticipated to hold the leading share of the global market during the forecast period. Breath analyzers are made to be simple to use and user-friendly. Even in a variety of healthcare settings, healthcare professionals can perform the test with efficiency and accuracy owing to its simplicity. Breath analyzers offer quick results, frequently in a short amount of time. This short return time helps make decisions about diagnosis and treatment right away, improving patient care.

The UBT-kits segment is expected to account for a considerable share of the worldwide market during the forecast period.

Urea Breath Test Market – By Instrument:

• Mass Spectrometer
• Infrared Spectrometer
• Laser Assisted Rationalizer

Based on the instrument, the infrared spectrometer segment is estimated to have the leading share of the global market during the forecast period. The sensitivity, precision, non-invasiveness, and real-time capabilities of infrared spectrometers majorly drive the growth of the infrared spectrometer segment in the global urea breath test market. The usage of infrared spectrometers for H. pylori testing is projected to contribute considerably to market expansion as technology continues to advance and the demand for accurate and effective diagnostics develops.

The laser-assisted rationalizer segment is predicted to hold a notable share of the worldwide market during the forecast period. Technological advancements have improved laser-assisted analyzers significantly in the recent past in terms of sensitivity and accuracy of breath analysis. They can quantify minute variations in isotopic carbon dioxide levels with accuracy, making it possible to identify H. pylori infections with extreme precision. Rapid results are frequently provided by laser-assisted analyzers, which is particularly helpful for point-of-care testing and making fast treatment decisions.

Urea Breath Test Market – By End-User:

• Hospitals
• Clinics
• Diagnostic Centers

Based on end-user, the hospital segment held a major share of the global market during the forecast period. Hospitals frequently contain innovative medical facilities and equipment that make them ideal places to carry out complex diagnostic procedures such as urea breath testing. This attracts medical experts looking for reliable diagnostic tools. Various medical specialists frequently work at hospitals. For better patient treatment, coordination among gastroenterologists, oncologists, internists, and other specialists can be facilitated through urea breath testing.

The diagnostic centers segment is estimated to account for a substantial share of the worldwide market in the coming years. Due to its specialized services, technological advancements, increasing awareness, convenience, and patient-focused attitude, the diagnostic centers segment is predicted to witness promising growth in the global urea breath test market.

Urea Breath Test Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Geographically, the North American region held the largest share of the global market in 2022 and is predicted to continue to grow at a promising CAGR during the forecast period. The availability of advanced healthcare infrastructure across North America is one of the major factors propelling the North American market growth. The healthcare infrastructure in North America is the most advanced and includes hospitals, diagnostic centers, and medical facilities with the latest technology. The introduction of urea breath tests as a common diagnostic tool is supported by this infrastructure. Gastric problems, such as H. pylori infections and associated diseases, are very common in the area. The need for precise diagnostic tools like urea breath testing is fuelled by its prevalence. The North American region is a center for medical innovation and research. The use of urea breath tests is further fuelled by ongoing research that results in the development of more advanced diagnostic systems.

Europe region is anticipated to grow at a notable CAGR in the global market during the forecast period. Gastric diseases such as H. pylori infections and associated conditions are very common in the European region. The growing need for precise diagnostic tools such as urea breath testing is fuelled by its prevalence. In Europe, early detection and intervention are encouraged, with a heavy emphasis on preventative healthcare practices. This focus is supported by urea breath tests, which help in the early detection of H. pylori infections. For medical equipment and diagnostics, Europe has strict restrictions. The strong regulatory structure supports the reliability, validity, and quality of urea breath tests, which supports public acceptance of them.

The APAC region is expected to show a lucrative CAGR among all the regions in the global market during the forecast period. APAC has a diversified population that contributes to a higher occurrence of gastrointestinal conditions such as H. pylori infections. The need for precise diagnostic tools such as urea breath testing is driven by this rise in prevalence. The infrastructure for healthcare, including hospitals, clinics, and diagnostic facilities, is expanding quickly in several Asian countries. The implementation of urea breath tests is made possible by this expansion.

Latin America and the Middle East and Africa region are also anticipated to grow at a significant CAGR during the forecast period.

KEY MARKET PLAYERS:

Mayoli Spindler (Kibion AB), Otsuka Pharmaceutical Co. Ltd., Sercon Group, Meridian Bioscience, Paladin Labs Inc., Beijing Richen- Force Science & Technology Co., Ltd., Fisher Analysen Method GmbH (FAN), Avanos Medical, Inc., Beijing Binal Health Bio-Sci & Tech Co., Ltd, Kizlon Medical, and Gulf Coast Scientific, Inc. are a few of the notable companies in the global urea breath test market.